Johanna Olweus
@JOlweus
Group leader & Head of Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital; Professor, Inst. for Clin. Med., University of Oslo
ID:901748071712923648
https://www.ous-research.no/olweus/ 27-08-2017 10:07:48
144 Tweets
509 Followers
107 Following
It was fantastic to catch up with Lillian Siu from the #CancerGrandChallenges Scientific Committee at our #AACR24 stand today (1313).
Lillian was recently elected as AACR President-Elect for 2024-2025. Huge congratulations Lillian! 🎉
Join us at #ImmunoOnco24 and follow the inspiring talk of Johanna Olweus Johanna Olweus UiO - Medisinsk bibliotek!
🗓️Early bird registration till 18th of April vibconferences.be/events/recent-…
CCB_VIB_KUL VIB Conferences
We are grateful to our excellent SAB for their valuable advice! And to Ron Germain for sharing his spectacular data with us in Oslo Norges forskningsråd UiO - Det medisinske fakultet Oslounivsykehus
Fantastisk å være en del av MATCHMAKERS team og få et Cancer Grand Challenge Grant til Norden for første gang. Tusen takk til alle støttespillere! Kreftforeningen, Precision Immunotherapy Alliance Norges forskningsråd Oslounivsykehus UiO - Det medisinske fakultet Helse Sør-Øst RHF
Today is #WorldCancerDay . The theme is Close the Care Gap, which is about creating innovative strategies designed to confront health inequities.
It's been top of mind at #CancerGrandChallenges , too - cancer inequities was among our 9 newest challenges 👇 bit.ly/3SqQrKz
We are inviting submissions for our Special Issue on Developments in Cell Therapy ESMO IOTECH . Submission deadline: 8 March 2024. Find out more and submit your manuscript ➡️ spkl.io/60154sUYl
ESMO IOTECH
IOTECH aspires to provide a forum for today's leaders in the field of #ImmunoOncology .
We welcome:
➡️pre-clinical/clinical studies
➡️solid/haematological cancers
➡️technological advances that decipher & improve clinical outcomes
Get in touch today!
Excellent presentation by Kanutte Huse at #ASH oral session 622, presenting our study 'Reduced Immune cell infiltration in MHC class I negative DLBCL'.
@Kreftforeningen Precision Immunotherapy Alliance UiO - Det medisinske fakultet
#ScienceSaturday How can we identify tumor reactive T cells circulating in the blood? Using single cell transcriptomic profiling of tumor infiltrating lymphocytes (TIL) and blood lymphocytes, researchers at Surgery Branch identified a phenotypic signature of circulating T cells…
The number of KIR-HLA interactions predict CD8 T cell lifespan in humans. In this Journal of Clinical Investigation report comparing intra- and interindividual effects, Zhang et al show that indirect interactions prolong T cell life span independent of the KIR expression on single cells
(1/2)
#NobelPrize and how tightly coupled R&D and application must be - Johanna Olweus John-Arne Røttingen and I discuss in Aftenposten the fantastic story of covid and cancer vaccine development as shown by Özlem Türeci @BioNTech in talks Det Norske Videnskaps-Akademi and Oslounivsykehus
aftenposten.no/meninger/kroni…
Årets nobelpris i medisin viser at koblingen må være tett mellom innovasjon, forskning og anvendelse. CEPI mener verden kan stanse framtidige pandemier gjennom vaksineutvikling på 100 dager. John-Arne Røttingen Kjetil Tasken Johanna Olweus shorturl.at/cuwFG
#100DaysMission
Story out! An albumin fused ACE2 design that blocks all SARS-CoV-2 variants. The design has a long plasma half-life and can be delivered in a needle-free manner across mucosal surfaces. Precision Immunotherapy Alliance UiO - Det medisinske fakultet Norges forskningsråd NTNUnorway Leo James' Lab
dx.doi.org/10.1093/pnasne…
